Article
Carson City, NV-ScienceBased Health has received a patent for HydroEye, its oral formulation for the relief of dry eye.
Melt Pharmaceuticals reports positive Phase 3 topline efficacy results for MELT-300
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
FDA accepts NDA from Aldeyra Therapeutics for reproxalap for dry eye
Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD
FDA issues CRL to Astellas' Supplemental New Drug Application for avacincaptad pegol intravitreal solution (IZERVAY)
Ocugen announces positive preliminary data from OCU410 Phase 1 clinical trial for geographic atrophy